Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Plos One|January 12, 2018
Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza virusesYoung-Tae Lee, Eun-Ju Ko, Youri Lee, et al.
Immune Network|November 12, 2025
Virus-like Particle Vaccines Containing RSV Fusion Protein Cleavage Mutations Are Immunogenic and Protective in Cotton Rats With a Prime DoseHye Suk Hwang, Young-Man Kwon, Ki-Hye Kim, et al.
Asian Spine Journal|October 28, 2014
Quality of life in patients with osteoporotic vertebral fracturesSang-Pil Yoon, Seung-Hwan Lee, Chul-Hyun Ki, et al.
International Journal of Nanomedicine|July 24, 2015
Respiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophagesYoung-Tae Lee, Eun-Ju Ko, Hye Suk Hwang, et al.
Immunology|April 30, 2014
Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccinationYu-Na Lee, Young-Tae Lee, Min-Chul Kim, et al.
Antiviral Research|December 17, 2014
Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV diseaseYu-Na Lee, Hye Suk Hwang, Min-Chul Kim, et al.
Antiviral Research|August 7, 2015
Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virusYu-Na Lee, Min-Chul Kim, Young-Tae Lee, et al.
Human Vaccines & Immunotherapeutics|August 31, 2017
Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particlesYouri Lee, Young-Tae Lee, Eun-Ju Ko, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 15, 2015
Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutininYu-Na Lee, Hye Suk Hwang, Min-Chul Kim, et al.
Biomedicines|June 2, 2021
BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus InfectionKi-Hye Kim, Young-Tae Lee, Yoonsuh Park, et al.
Pageof 11